Kezar Life Sciences (KZR)
(Real Time Quote from BATS)
$0.63 USD
+0.01 (0.87%)
Updated Aug 16, 2024 11:52 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 29% (74 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.80 | 1.36 | 9.99 |
Current Quarter Estimate | -0.30 | -10.57 | 61.00 |
Year Ago Quarter Estimate | -0.32 | -3.51 | 54.84 |
Next Quarter Estimate | -0.31 | 3.27 | 63.00 |
Next Year Estimate | -1.18 | 25.31 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 7.63 | 17.60 | 15.67 |
Next Year | 2.48 | 9.00 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 21.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -8.79 |
Price/Book (MRQ) | 0.30 | 1.91 |
Price/Cash Flow (MRFY) | NA | 15.24 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -87.29% |
Return on Equity (TTM) | -50.26% | -47.30% |
Debt to Equity (MRQ) | 0.05 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.